Demyelinating Disorders

Barkhof F, Filippi M, Miller DH, Ader HJ. Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis. Neuroradiology 1999;41:347–350.PubMedCrossRefGoogle Scholar

Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127(Part 5):1101–1107.PubMedCrossRefGoogle Scholar

Fangerau T, Schimrigk S, Haupts M, et. al. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand 2004;109:385–389.PubMedCrossRefGoogle Scholar

McDonald WI, Compton A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127.PubMedCrossRefGoogle Scholar

Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231.PubMedCrossRefGoogle Scholar

Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of multiple sclerosis. Ann NY Acad Sci 1965;122:552–568.CrossRefGoogle Scholar

Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;47:831–835.PubMedCrossRefGoogle Scholar

Tintore M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003;60:27–30.PubMedCrossRefGoogle Scholar

Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol 2002;22:105–122.PubMedCrossRefGoogle Scholar

de Seze J, Stojkovic T, Ferriby D, et al. Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002;197:57–61.PubMedCrossRefGoogle Scholar

Devic E. Myelite aigue dorse-lombaire avec névrite optique, autopsie. Congrés français de méd [in French]. Premiére Session, Lyon 1895;1:434–439.Google Scholar

Devic E. Myélite subaiguë compliquée de névrite optique [in French]. Bull Med (Paris) 1894;8:1033–1034.Google Scholar

Gault F. De la neuromyélite optique aiguë [in French]. PhD thesis, Lyons, France: 1894.Google Scholar

Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162–168.PubMedCrossRefGoogle Scholar

O’Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatr 1996;60:382–387.PubMedCrossRefGoogle Scholar

Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981;49:253–271.PubMedCrossRefGoogle Scholar

Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999;53:1107–1114.PubMedGoogle Scholar

Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981;31:966–971.PubMedGoogle Scholar

Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993;50:532–535.PubMedGoogle Scholar

Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1979:4:51–59.CrossRefGoogle Scholar

Transverse myelitis consortium working group. Proposed diagnostic criteria and nosology of transverse myelitis. Neurology 2002;59:499–505.Google Scholar